Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantation.

about

Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantation.

Item

http://www.wikidata.org/entity/Q49332656

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Low dose anti-thymocyte globul ...... related donor transplantation.

@en

Low dose anti-thymocyte globul ...... related donor transplantation.

@nl

type

Item

label

Low dose anti-thymocyte globul ...... related donor transplantation.

@en

Low dose anti-thymocyte globul ...... related donor transplantation.

@nl

prefLabel

Low dose anti-thymocyte globul ...... related donor transplantation.

@en

Low dose anti-thymocyte globul ...... related donor transplantation.

@nl

P1476

Low dose anti-thymocyte globul ...... related donor transplantation.

@en

P2093

Anand Tandra

http://www.w3.org/2001/XMLSchema#string

Ben Tomlinson

http://www.w3.org/2001/XMLSchema#string

Bernadette McQuigg

http://www.w3.org/2001/XMLSchema#string

Brenda Cooper

http://www.w3.org/2001/XMLSchema#string

Ehsan Malek

http://www.w3.org/2001/XMLSchema#string

Hillard M Lazarus

http://www.w3.org/2001/XMLSchema#string

Lauren Brister

http://www.w3.org/2001/XMLSchema#string

Leland Metheny

http://www.w3.org/2001/XMLSchema#string

Marcos de Lima

http://www.w3.org/2001/XMLSchema#string

Merle Kolk

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the intensity of conditioning regimens: working definitions

The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML.

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide

Immunobiology of allogeneic hematopoietic stem cell transplantation.

P304

1644-1651

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1390234

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

F Otegbeye

F Covut

P577

2017-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29199482

http://www.w3.org/2001/XMLSchema#string